The Middle EAST Blood Coagulants Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.8%. This growth trajectory is underpinned by several factors, including the rising prevalence of bleeding disorders, increasing surgical procedures, and a growing geriatric population that is more susceptible to conditions requiring blood...